Home/Filings/4/0001638599-17-001158
4//SEC Filing

Sands Earl 4

Accession 0001638599-17-001158

CIK 0001453687other

Filed

Nov 20, 7:00 PM ET

Accepted

Nov 21, 4:08 PM ET

Size

8.8 KB

Accession

0001638599-17-001158

Insider Transaction Report

Form 4
Period: 2017-11-17
Sands Earl
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2017-11-17$10.26/sh+7,500$76,9677,500 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.21 to $10.2887, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) of this Form 4.

Issuer

SELECTA BIOSCIENCES INC

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0001676902

Filing Metadata

Form type
4
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 4:08 PM ET
Size
8.8 KB